Aurobindo Pharma Ltd.'s second-quarter profit fell year-on-year, missing estimates.
WRITTEN BY
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU

USFDA Issues Form 483 With Eight Observations To Aurobindo's Telangana Unit


Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains 'Buy' — Check Target Price


Aurobindo Pharma Q1 Results: Profit Falls 10%, Misses Estimates


Aurobindo Pharma Declares Dividend Of Rs 4 — Check Record Date, Details
